• Kiniksa Pharmaceuticals Chairman and CEO Sanj K Patel reported sales of 508,339 Class A ordinary shares on April 28 at weighted average prices of USD 50.43, USD 51.47, USD 52.02.
• Patel also sold 51,750 Class A ordinary shares on April 28 at weighted average price USD 54.02.
• Additional sales totaled 24,685 Class A ordinary shares on April 29-30 at weighted average price USD 54.01.
• Transactions followed option exercises totaling 508,339 shares at USD 10.36 and USD 30.93 on April 28-30.
• Patel ended period with 237,763 Class A ordinary shares held indirectly through trusts.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kiniksa Pharmaceuticals International plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001532218-26-000006), on April 30, 2026, and is solely responsible for the information contained therein.